Virtu Financial’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$665K Buy
+16,363
New +$702K 0.02% 443
2025
Q3
– Sell
-34,004
Closed -$466K – 2119
2025
Q2
$466K Buy
+34,004
New +$326K 0.02% 599
2018
Q3
– Sell
-13,485
Closed -$671K – 2221
2018
Q2
$671K Buy
13,485
+5,848
+77% +$340K 0.04% 626
2018
Q1
$379K Buy
+7,637
New +$383K 0.02% 875

Other funds holding URGN

Virtu Financial's URGN Position: Q3 2026 in Review

Virtu Financial opened a new position in UroGen Pharma (URGN) in Q3 2026: 16,363 shares worth $665K. The stake represents 0.02% of the portfolio and ranks #443 among its holdings. This is a return to the name: Virtu Financial previously reported a position in URGN as recently as Q2 2025.

Virtu Financial first reported a position in URGN in Q1 2018 and has held it in 4 quarters since. The position peaked at $671K in Q2 2018. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

  • Virtu Financial held 16,363 shares of UroGen Pharma worth $665K as of Q3 2026.
  • UroGen Pharma was a new Virtu Financial position in Q3 2026.
  • UroGen Pharma made up 0.02% of Virtu Financial's portfolio in Q3 2026, its #443 holding.
  • Virtu Financial first reported a position in UroGen Pharma in Q1 2018 and has held it in 4 quarters since.
  • Virtu Financial's UroGen Pharma position peaked at $671K in Q2 2018.
  • 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.